Thyroid Disease & Dermatology
Thyroid hormones (T3, triiodothyronine, and T4, thyroxine) set the metabolic pace of almost every tissue in the body, and the skin is one of their most responsive targets. They govern how quickly keratinocytes mature, how hair follicles cycle, how sweat and sebaceous glands work, how much glycosaminoglycan (GAG) dermal fibroblasts produce, and how blood flows through the skin's microcirculation. Whether the thyroid is underactive (hypothyroidism) or overactive (hyperthyroidism, most often Graves' disease), the result is a recognizable set of tissue changes, which makes the skin an early window onto chronic endocrine disease.
What happens in the skin and connective tissue:
- In Hypothyroidism:
- Slower epidermal turnover: With low T3 and T4, keratinocytes take longer to travel from the basal layer to the stratum corneum. Dead cells build up, and the skin becomes rough, dry and scaly (xerosis).
- Reduced gland activity and carotene build-up: Eccrine sweat glands and sebaceous glands shrink slightly and sweating decreases (hypohidrosis), so the skin loses its protective lipid–water film. The liver also converts carotene to vitamin A less efficiently, so carotene collects in the stratum corneum and gives the skin a pale yellow tint. The whites of the eyes stay white, which distinguishes this from jaundice caused by bilirubin.
- Generalized myxedema: Thyroid hormone deficiency slows the breakdown of glycosaminoglycans in the dermis, mainly hyaluronic acid and chondroitin sulfate. These GAGs accumulate and draw in large amounts of water, producing a firm, non-pitting swelling throughout the body that is most obvious on the face and eyelids.
- In Hyperthyroidism (Graves' Disease):
- Increased metabolism and dilated skin vessels: Excess thyroid hormone raises oxygen consumption and body temperature. To shed heat, the skin dilates its small vessels widely and sweats more (hyperhidrosis), so it feels persistently warm, moist and unusually soft and smooth.
- Pretibial myxedema (infiltrative dermopathy): Seen in 1–5% of people with Graves' disease. The autoantibodies that stimulate the TSH receptor (TRAb) bind not only to the thyroid but also to TSH receptors on dermal fibroblasts in the shins. The fibroblasts respond by producing large amounts of GAGs, leading to swelling, fibrosis and characteristic thickened plaques with a brick-red or orange color.
At Haute-Derma, treating thyroid-related skin disorders means working on two fronts at once: getting the underlying thyroid function under control and repairing the structural damage in the skin itself.
Skin, Hair and Nail Signs by Thyroid Status
| Organ / Structure | Hypothyroidism | Hyperthyroidism (Graves' Disease) |
|---|---|---|
| Skin Surface and Temperature | Dry, rough, cool skin with reduced sweating. Pale or yellowish tint (carotenemia). | Warm, moist, smooth skin with increased sweating (especially palms and soles) and facial flushing. |
| Dermal Infiltration | Generalized myxedema: dull, expressionless face, puffy eyelids, enlarged lips and tongue, non-pitting infiltration. | Pretibial myxedema: raised, thickened pink to brick-red plaques with an orange-peel surface on the shins. |
| Hair | Dry, coarse, brittle hair with diffuse shedding (telogen effluvium). Queen Anne's sign: loss of the outer third of the eyebrows. | Fine, soft, silky hair with diffuse shedding (telogen effluvium); may be accompanied by autoimmune vitiligo. |
| Nails | Thin, brittle, slow-growing nails with longitudinal ridging. | Plummer's nails: separation of the nail from the nail bed (onycholysis) with an upturned free edge. |
Generalized vs. Pretibial Myxedema
| Feature | Generalized Myxedema | Pretibial Myxedema |
|---|---|---|
| Underlying Condition | Severe, long-standing hypothyroidism (Hashimoto's, after thyroid surgery or I-131) | Autoimmune Graves' disease (hyperthyroidism); rare in Hashimoto's |
| Molecular Mechanism | Reduced GAG breakdown due to T3/T4 deficiency | TRAb antibodies stimulating TSH receptors on fibroblasts |
| Lesion Pattern | Diffuse infiltrated swelling of the body, face, eyes and lower legs | Raised, firm plaques or nodules, red-brown to yellow-orange, on the front of the shins |
| Type of Swelling | Non-pitting; skin cool and pale | Non-pitting; enlarged follicular openings giving an orange-peel look |
| Associated Symptoms | Cold intolerance, weight gain, constipation, slow heart rate, fatigue | Graves' eye disease (proptosis), thyroid acropachy |
Medical Management at Haute-Derma
At Haute-Derma, we follow a standardized approach to thyroid-related skin problems, designed to support tissue recovery while keeping treatment safe:
Initial Medical Assessment and Screening
- Thyroid function and autoimmune testing: TSH, FT3 and FT4 are always measured, along with anti-TPO and anti-TG antibodies (to screen for Hashimoto's) or TRAb (to screen for Graves' disease).
- Skin barrier and hair follicle assessment: Skin imaging devices are used to assess transepidermal water loss (TEWL), follicle density and stratum corneum thickness.
Targeted Local Treatment
- Restoring Dry Skin and Myxedema in Hypothyroidism:
- Replenishing barrier lipids: Moisturizers with ceramides in a 3:1:1 ratio, multi-weight hyaluronic acid and 5–10% urea help normalize shedding of the outer skin layer and lock in moisture.
- Stimulating regrowth after telogen shedding: Once thyroid function has been stabilized with levothyroxine, we combine topical minoxidil with red LED light therapy (630 nm) to boost blood flow around the follicles.
- Controlling Pretibial Myxedema in Graves' Disease:
- High-potency topical steroid under occlusion: Clobetasol propionate 0.05% is applied to the plaques, which are then wrapped overnight in plastic film or a medical stocking to suppress GAG production by fibroblasts.
- Intralesional steroid injection: Triamcinolone acetonide (5–10 mg/ml) is injected directly into firm, progressing nodules.
- Managing Associated Autoimmune Pigment Loss (Vitiligo): A topical calcineurin inhibitor (tacrolimus 0.1%) combined with narrowband UVB phototherapy helps restore melanocytes.
Treatments We Do Not Offer in These Situations
- No destructive or invasive procedures (ablative CO2 laser, deep chemical peels, microneedling) on pretibial myxedema: The shin dermis in Graves' disease is loaded with GAGs and actively inflamed. Any mechanical or thermal injury can trigger the Köbner phenomenon, spreading the lesions and slowing healing.
- No high-heat laser/IPL hair removal or hot steam massage in uncontrolled hyperthyroidism: At best, the already warm, vasodilated skin is prone to thermal burns; at worst, the heat and pain can provoke a thyroid storm.
- No invasive hair-loss treatments before TSH has normalized: Thyroid-related hair loss is a metabolic problem. Invasive scalp procedures done while hormone levels are still unstable will not work and waste the patient's money.
